Earnings Call · Q3 FY2024·2024-11-06

Q3 24EPS -2.04%·Rev n/aQ2 24EPS +25.33%·Rev n/aQ1 24EPS +31.65%·Rev n/aQ4 23EPS -3.30%·Rev n/a⚠ consensus missing

Amphastar Pharmaceuticals, Inc. AMPH

Dan Dischner — CEO

Bill Peters — CFO and Executive Vice President of Finance

−13.7%1d on move date−14.5% vs SPY3d−9.0%5d−14.8%

Research tier

Behavioral profile computed for 2 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more AMPH calls or request research access.

More AMPH calls Browse calls Request research access